Long term prognosis of chronic heart failure - Reduced vs preserved left ventricular ejection fraction

Circulation Journal

Volumn 73, Issue 1, 2009, Pages 92-99

  Miyagishima, Kenji ^a   Hiramitsu, Shinya ^a   Kimura, Hisashi ^a   Mori, Kazumasa ^a   Ueda, Tomoya ^a   Kato, Shigeru ^a   Kato, Yasuchika ^a   Ishikawa, Shiho ^a   Iwase, Masatsugu ^a   Morimoto, Shin Ichiro ^a   Hishida, Hitoshi ^a   Ozaki, Yukio ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic heart failure; Ejection fraction; Preserved LV function; Prognosis; Reduced LV function

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; PHOSPHODIESTERASE III INHIBITOR; PIMOBENDAN; SPIRONOLACTONE;

ADULT; AGED; ANEMIA; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS;

AGED; AGED, 80 AND OVER; ANEMIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION;

EID: 58549097092     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-1016     Document Type: Article

References (34)

1. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med 1991; 325: 1557-1564.
2. Zile MR, Brutsaert DL. New concept in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.
3. Zile MR, Brutsaert DL. New concept in diastolic dysfunction and diastolic heart failure: Part II causal mechanism and treatment. Circulation 2002; 105: 1503-1508.
4. Aurigemma GP, Gaasch WH. Diastolic Heart Failure. N Engl J Med 2004; 351: 1097-1105.
5. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959.
6. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2004; 43: 317-327.
7. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446.
8. Senni M, Redfield MM. Heart failure with preserved systolic function: A different natural history? J Am Coll Cardiol 2001; 38: 1277-1282.
9. Galderisi M. Diastolic dysfunction and diastolic heart failure: Diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound 2005; 3: 9.
10. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R, et al. Congestive heart failure despite normal left systolic function in a population-based sample: The Strong Heart Study. Am J Cardiol 2000; 86: 1090-1096.
11. Redfield MM, Jacobsen SJ, Burnet JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003; 289: 194-202.
12. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiology characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150.
13. Vasan RS, Larson MG, Benjamin EJ, Evans SC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33: 1948-1955.
14. Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure, a study in Fukuoka, Japan. Jpn Circ J 2000; 64: 953-959.
15. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001; 88: 530-533.
16. Shinozaki T, Watanabe J, Kikuchi J, Tamaki K, Hoshi N, Hayashi M, et al; The DIAST Investigators. Rationale, design, and organization of the diastolic heart failure assessment study in Tohoku District (DIAST). Circ J 2004; 68: 660-664.
17. Okura Y, Ohno Y, Ramadan MM, Suzuki K, Taneda K, Obata H, et al. Characterization of outpatients with isolated diastolic dysfunction and evaluation of the burden in a Japanese community: Sado Heart Failure Study. Circ J 2007; 71: 1013-1021.
18. Vasan RS, Levy D. Defining diastolic failure: A call for standardized diagnostic criteria. Circulation 2000; 101: 2118-2121.
19. Garcia MJ, Thomas ID, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-875.
20. Arques S, Ambrosi P, Roux E, Habib G. Potentials and limitations of color M-mode and tissue doppler indexes in identifying pseudonormal mitral filling pattern in patients with acute symptoms of heart failure and preserved left ventricular systolic function. Am J Cardiol 2004; 93: 1057-1060.
21. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and cotractility in patients with diastolic heart failure. Circulation 2005; 111: 2306-2312.
22. Oyama R, Muraoka K, Tanaka N, Takaki A, Ueda K, Liu J, et al. Is the ratio of transmitral peak E-wave velocity to color flow propagation velocity useful for evaluating the severity of heart failure in atrial fibrillation? Circ J 2004; 68: 1132-1138.
23. Nakao S, Goda A, Yuba M, Otsuka M, Matsumoto M, Yoshida C, et al. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure. Circ J 2007; 71: 1412-1417.
24. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777-781.
25. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, et al; for the Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005; 112: 3738-3744.
26. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
27. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
28. Ahmed A, Perry GJ, Fleg JL, Love TE, Goff DC Jr, Kitzman DW. Outcomes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis. Am Heart J 2006; 152: 956-966.
29. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: Mortality, readmission, and functional decline. J Am Coll Cardiol 2003; 41: 1510-1518.
30. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47: 76-84.
31. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, et al; New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004; 43: 1432-1438.
32. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007; 50: 768-777.
33. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: 154-235.
34. Hori M, Kitabatake A, Tsutsui H, Okamoto H, Shirato K, Nagai R, et al; The J-DHF Program Committee. Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF). J Card Fail 2005; 11: 542-547.